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Routine Testing for Anaerobic Bacteria in Cerebrospinal Fluid
Cultures Improves Recovery of Clinically Significant Pathogens
Meredith E. Pittman,a Benjamin S. Thomas,b Meghan A. Wallace,a Carol J. Weber,c Carey-Ann D. Burnhama

In North America, the widespread use of vaccines targeting Haemophilus influenzae type b and Streptococcus pneumoniae have
dramatically altered the epidemiology of bacterial meningitis, while the methodology for culturing cerebrospinal fluid (CSF)
specimens has remained largely unchanged. The aims of this study were 2-fold: to document the current epidemiology of bacterial meningitis at a tertiary care medical center and to assess the clinical utility of routinely querying for anaerobes in CSF cultures. To that end, we assessed CSF cultures submitted over a 2-year period. A brucella blood agar (BBA) plate, incubated anaerobically for 5 days, was included in the culture procedure for all CSF specimens during the second year of evaluation. In the preand postimplementation years, 2,353 and 2,302 CSF specimens were cultured, with 49 and 99 patients having positive culture
results, respectively. The clinical and laboratory data for patients with positive cultures were reviewed. Anaerobic bacteria were
isolated in the CSF samples from 33 patients post-BBA compared to two patients pre-BBA (P ⴝ 0.01). The anaerobic isolates included Bacteroides thetaiotaomicron (n ⴝ 1), Propionibacterium species (n ⴝ 15), and Propionibacterium acnes (n ⴝ 19) isolates; all of these isolates were recovered on the BBA. Eight of the 35 patients from whom anaerobic organisms were isolated received antimicrobial therapy. Although six of these patients had central nervous system hardware, two patients did not have a
history of a neurosurgical procedure and had community-acquired anaerobic bacterial meningitis. This study demonstrates that
the simple addition of an anaerobically incubated BBA to the culture of CSF specimens enhances the recovery of clinically significant anaerobic pathogens.

T

he epidemiology of bacterial meningitis in developed countries
has changed dramatically over the last 3 decades. As recently as the
1980s in the United States, three pathogens, Haemophilus influenzae,
Streptococcus pneumoniae, and Neisseria meningitidis, accounted
for ⬎80% of community-acquired bacterial meningitis cases (1,
2). With the introduction of vaccines directed at H. influenzae type
b, S. pneumoniae, and N. meningitis, a dramatic decline has occurred in the rate of central nervous system infection caused by
these organisms.
The contemporaneous emergence of immunocompromised
patient populations and increasing antimicrobial resistance in
bacterial pathogens has further contributed to the evolution of
this disease. Patients with chronic diseases and/or chronic immunosuppression are living longer and are susceptible to infections
caused by pathogens typically thought to be of low virulence (3, 4).
Additionally, patients who undergo neurosurgical procedures or
have ventriculoperitoneal shunts in place are at high risk for subsequent infection. The rates of infection are reported to be as high
as 11 to 18% per patient after initial shunt placement (5, 6).
The protocols used by clinical microbiology laboratories for
the culture of cerebrospinal fluid (CSF) specimens have been relatively static for many decades. Although attempts have been
made to develop sophisticated assays to detect bacterial pathogens, these tests have not been shown to improve upon bacterial
culture (7–10). The mainstay of CSF culture remains the inoculation of specimens to blood and chocolate agar plates and incubation at 35°C in an environment with 5% CO2 (11). As a result of
the altered landscape of bacterial meningitis, now is the ideal time
for a reevaluation of culture methods for CSF specimens.
The objectives of this study were to evaluate the current epidemiology of pathogenic organisms recovered from CSF cultures at
a tertiary care academic medical center and to evaluate the impact
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of adding a single piece of medium, incubated anaerobically, on
the recovery of anaerobic organisms that are clinically relevant in
the contemporary era of bacterial meningitis.
MATERIALS AND METHODS
Laboratory methods. Cytospin Gram stains were prepared on all CSF
specimens submitted to the laboratory. If ⬎2 ml of CSF was received by
the laboratory, the specimen was centrifuged and the sediment was inoculated onto solid agar. Prior to 3 January 2012, all CSF specimens submitted to the Barnes-Jewish Hospital microbiology laboratory for bacterial
culture were inoculated onto sheep blood agar (SBA) and chocolate agar
(Remel, Lenexa, KS) and incubated in 5% CO2 for a minimum of 48 h to
observe for growth. After 3 January 2012, a prereduced brucella blood
agar (BBA) plate (Hardy Diagnostics, Santa Maria, CA), incubated anaerobically, was added to the standard CSF specimen protocol. The BBA agar
is routinely held for 48 h prior to being examined, and the anaerobic
medium is held for a total of 5 days to observe for growth. Any organism
recovered in culture was identified according to the laboratory standard
operating procedures, typically involving a combination of Gram staining, spot tests, and phenotypic profiling.
Data collection. The microbiology laboratory database was queried
for all CSF cultures submitted within 1 year prior to and 1 year following
the introduction of BBA. All positive CSF cultures were linked with patient data collected from the electronic medical record, including patient
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TABLE 1 Demographics and clinical characteristics of patients with
positive CSF cultures
Data by BBA year

Patient characteristica

Pre-BBA
(n ⫽ 49
[33%])

Post-BBA
(n ⫽ 99
[67%])

Pb

Mean age (range) (yr)

54 (21–94)

50 (19–94)

0.22

Sex
Men
Women

24 (49)
25 (51)

62 (63)
37 (37)

0.11

0.29c

Race
White
Black
Other

27 (55)
21 (43)
1 (2)

64 (65)
34 (34)
1 (1)

Presenting symptoms
Headache
Altered mental status
Nausea/vomiting
Fever

25 (51)
24 (49)
10 (20)
12 (24)

49 (49)
52 (53)
20 (20)
15 (15)

Discharge diagnoses
Bacterial meningitis
Cryptococcal meningitis
VP shunt malfunction
Seizure disorder

12 (24)
8 (16)
3 (6)
1 (2)

8 (8)
9 (9)
12 (12)
11 (11)

Mean no. of days in hospital (range)

16 (0–85)

11 (0–86)

0.016

CNS hardware placed
Recent (within past 90 days)
Remote (ⱖ90 days ago)

17 (35)
14
3

22 (22)
18
5

0.10
0.70

Surgery (past 90 days)
Neurosurgery
Other

21 (43)
19 (90)
2 (10)

20 (20)
16 (80)
4 (20)

0.004d
0.4

Immunocompromised
HIV/AIDS
Solid-organ transplant
Chronic steroids
Chemotherapy

17 (35)
8 (16)
0
7 (14)
4 (8)

28 (28)
9 (9)
3 (3)
8 (8)
10 (10)

0.43

RESULTS

Patient population. In the 12 months prior to the BBA addition,
2,352 CSF specimens were submitted to the laboratory for bacterial culture, resulting in 69 positive cultures (2.9%) from 49 patients. In the 12 months following the addition of the BBA, 2,302
CSF specimens were submitted for bacterial culture, resulting in
113 positive cultures (4.9%) from 99 patients, a statistically significant difference in positive culture results (P ⬍ 0.001). A sample
from one patient was present in both the pre- and the post-BBA
data, but all other patient samples were unique. The demographic
and clinical characteristics of the 148 patients with positive CSF
cultures are presented in Table 1. During both of the time periods
evaluated, the patient populations were similar with regard to
their presenting symptoms and discharge diagnoses. Additionally,
the number of patients who were immunosuppressed (45 [30.2%]
overall) and who had central nervous system hardware (39
[26.2%] overall) did not vary between the groups. Of interest, the
patients in the pre-BBA year were more likely to have recently
(within 90 days) had a surgical procedure (42.9%; P ⫽ 0.004),
although the difference between those with neurosurgical and
nonneurosurgical procedures was not statistically different (P ⫽
0.4).
Culture results. One hundred fifty-one isolates were recovered
over the study period from 148 patients (Table 2). Of these, only
eight (0.5%) of the pathogens recovered were what would be considered “classic” pathogens in bacterial meningitis. One culture
grew H. influenzae, one culture grew N. meningitidis (group B),
and six cultures grew S. pneumoniae.
The majority of patients evaluated in this study had only one
positive CSF culture result. Eighteen patients had more than one
positive CSF culture result (n ⫽ 52) during a single period of
illness. For 15 of these patients, the subsequent culture result
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a
Unless otherwise indicated, patient characteristic data are presented as the number
(%) of subjects.
b
P values in bold type are those that are statistically significant at a P value of ⬍0.05.
c
“Other” race category excluded from analysis.
d
The proportions of patients who underwent an operation in the pre-and post-BBA
years are significantly different, while the types of procedures between groups are not.

matched the original culture result (46 total cultures), and therefore only the initial culture result is presented in Table 2. In the
remaining three patients (2 cultures each), the original CSF culture did not match the subsequent CSF culture result. One patient
had Aspergillus fumigatus, followed by coagulase-negative staphylococci (CoNS), one patient had CoNS followed by Propionibacterium acnes, and one patient had CoNS followed by Staphylococcus aureus. These six culture results are reflected in Table 2. The
patient represented in both pre- and post-BBA periods grew Cryptococcus neoformans at both time points.
Additionally, 83 patients had blood cultures drawn during
their hospital visit, with 25 patients having a positive blood culture
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history, presenting symptoms, culture results, patient outcome, and discharge diagnoses as enumerated in the physician discharge summary. Patients with more than one CSF culture submitted per visit had all positive
culture results reviewed. For patients whose initial positive culture result
matched those of the subsequent cultures, the initial culture result was
utilized in statistical analyses. For the three patients whose subsequent
culture results differed from those of the initial cultures (n ⫽ 6), the
culture considered to be most clinically significant (see Results) was used
in the statistical analysis.
The clinical significance of the recovery of an organism in culture was
inferred from the decision of the clinicians to initiate or continue treatment with antimicrobials once the culture results became available. If
empirical antimicrobials had been given but were stopped at the time of
culture results, these patients were not considered to be treated for meningitis. As a separate but related measure of clinical significance, an infectious diseases specialist, blinded to actual treatment course, performed an
independent review of presenting symptoms, medical comorbidities, CSF
profile, and CSF culture results and gave a retrospective treatment recommendation. Thus, the clinical significance of the isolates recovered in culture was determined both prospectively and retrospectively by medical
professionals.
Statistical analysis. Student’s t test or Mann-Whitney U test for independent samples were used to compare the means and distributions of
patient populations for the appropriate parametric data or nonparametric
data, respectively. Chi-square or Fisher’s exact tests were used to describe
categorical differences between the patient populations and culture results. A kappa statistic was calculated for the agreement between the prospective and retrospective evaluations of clinical significance of the isolates recovered in culture. Statistical analyses were performed using SPSS
Statistics version 20 software (IBM Corp., Armonk, NY).

Pittman et al.

TABLE 3 Patients with discrepant blood and CSF culture resultsa

TABLE 2 Isolates recovered from CSF specimen cultures
No. of isolates by BBA
year
Post-BBA
(n ⫽ 102)

Pa

Aerobic
Anaerobic

47
2

69
33

0.01

Bacillus spp., not B. anthracis
Bacteroides thetaiotaomicron
Citrobacter koseri

0
0
0

3
1
1

Coagulase-negative Staphylococcus spp.
(n ⫽ 50)
CoNS not otherwise specified
Staphylococcus capitis
Staphylococcus epidermidis
Staphylococcus hominis
Staphylococcus warneri

18
0
1
0
0

23
1
5
1
1

Corynebacterium spp.
Enterobacter aerogenes
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Gram-negative bacilli
Haemophilus influenzae
Klebsiella pneumoniae
Micrococcus spp.
Mixed skin microorganisms
Neisseria meningitidis, group B
Propionibacterium acnes
Propionibacterium spp.
Pseudomonas aeruginosa
Staphylococcus aureus
Streptococcus mitis group
Streptococcus pneumoniae
Viridans group Streptococcus

1
2
1
2
1
3
0
0
0
0
0
2
0
2
2
0
5
0

3
0
1
0
0
0
1
1
3
1
1
17
15
1
5
2
1
1

Yeast/fungus (n ⫽ 22)
Aspergillus fumigatus
Candida albicans
Candida parapsilosis
Candida spp.
Cryptococcus neoformans
Unspecified yeast

0
0
1
0
7
1

1
2
0
1
9
0

a

Coagulase-negative staphylococcal
species
S. epidermidis
S. aureus
Gram-negative bacillus (Gram stain
only)
Candida sp., not C. albicans
Propionibacterium acnes
CoNS sp.
CoNS sp.
CoNS sp.

a
The results from each culture are shown alongside each other (e.g., an isolate defined
as Acinetobacter calcoaceticus-A. baumannii complex in blood culture was identified as
coagulase-negative staphylococci species by CSF culture).

<0.001

result (30.1%). Sixteen of these positive results (64.0%) confirmed
the same isolate in both blood and CSF specimens: CoNS (n ⫽ 1),
C. neoformans (n ⫽ 6), Enterobacter aerogenes (n ⫽ 2), Enterococcus faecium (n ⫽ 1), Klebsiella pneumoniae (n ⫽ 1), S. aureus (n ⫽
2), and S. pneumoniae (n ⫽ 3). Nine patients had distinct isolates
as determined from the blood and CSF methods, and these results
are listed in Table 3.
Anaerobic culture results. Thirty-five isolates of anaerobic
bacteria were recovered during the 2-year study period. In the
pre-BBA year, 2 CSF cultures (4% of positive CSF cultures) resulted in the isolation of anaerobic bacteria, both from P. acnes. In
the post-BBA year, 33 CSF cultures (32% of the positive CSF cultures) were positive for the growth of anaerobic bacteria (P ⫽
0.01). These post-BBA isolates included 15 Propionibacterium spp.

jcm.asm.org

Acinetobacter calcoaceticus-A.
baumannii complex
C. parapsilosis
CoNS sp. not otherwise specified
E. aerogenes
P. aeruginosa
P. aeruginosa
Streptococcus agalactiae
S. agalactiae
S. mitis group

P values in bold type are those that are statistically significant at a P value of ⬍0.05.
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Patient CSF isolate

isolates, 17 P. acnes isolates, and one B. thetaiotaomicron isolate.
Of note, the two P. acnes cultures from the pre-BBA year were
plated to and isolated on a BBA plate because of high clinical
suspicion due to the presence of a ventriculoperitoneal (VP) shunt
in the respective patients. All 35 anaerobic isolates grew on the
anaerobically incubated BBA. Only one isolate, a P. acnes, also
grew as pinpoint colonies on the aerobically incubated chocolate
agar.
Aerobic medium is first examined after overnight incubation,
but the BBA plate is typically not examined until it has been incubated for 2 days. The growth of aerobic isolates therefore became
apparent within a median of 2 days (interquartile range [IQR], 1
to 3 days), while anaerobic isolates were noted at 3 days (IQR, 2 to
4; P ⬍ 0.001). Anaerobic isolates were recovered in a similar number of patients with and without central nervous system (CNS)
hardware (22.0 versus 23.6% of positive cultures, respectively; P ⫽
0.827) and in immunocompetent and immunocompromised patients (27.2 versus 13.3% of positive cultures, respectively; P ⫽
0.089). On the other hand, patients who had undergone a neurosurgical operation within 90 days of CSF culture were less likely to
have growth of anaerobic bacteria than those who had not had
surgery (6.5 versus 33.7%, respectively; P ⫽ 0.002).
Clinical significance and antimicrobial therapy. Overall, patients were administered antimicrobial therapy for 46.4% (n ⫽
70) of the isolates recovered. Of the 22 patient samples from which
yeast or fungal organisms were cultured, 21 patients received
treatment; one patient expired due to other causes prior to the
CSF results becoming available. The majority of samples with
yeast or fungal isolates were from immunocompromised patients
(72.7%; P ⬍ 0.001).
In a comparison of the clinical decision to treat the patient at
the time of culture with the retrospective recommendation of an
infectious diseases specialist during chart review, the agreement
was excellent ( ⫽ 0.94).
Factors involved in decision to treat. For the cultures with
bacterial growth, 49 patients (38%) were considered to have bacterial meningitis and were treated with antimicrobials accordingly. Treatment was more likely to be recommended if the patient
presented with a fever (60.0 versus 34.0%; P ⫽ 0.028), had a recent
neurosurgical procedure (87.1 versus 22.1%; P ⬍ 0.001), or possessed CNS hardware (72.2 versus 24.7%; P ⬍ 0.001). Treatment
was less likely, however, if the patient presented with seizure activity (21.1 versus 50.4%; P ⫽ 0.025). The median CSF nucleated
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Organism

Pre-BBA
(n ⫽ 49)

Patient blood isolate

Anaerobic Bacteria in CSF Cultures

TABLE 4 Analysis of CSF specimens with bacterial growth

TABLE 5 Evaluation of patients with isolation of anaerobic isolates who
did or did not receive antimicrobial therapy

Median (IQR) values by
antimicrobial treatment status
a

Treated

Untreated

P

704 (25, 1,607)
78 (21, 88)
8 (2, 18)
111 (46, 376)
23 (20, 68)

0 (0, 6)
2 (0, 17)
65 (33, 81)
68 (29, 69)
68 (55, 77)

⬍0.001
⬍0.001
⬍0.001
⬍0.001
⬍0.001

a
Treated, indicates that these patients were treated with appropriate antimicrobials
after the culture results had been finalized.
b
All P values are significant at ⬍0.05.

cell count was significantly higher in the group that received antimicrobial therapy (704 cells/l [IQR, 25 to 1,607 cells/l]) than in
the untreated group (0 cells/l [IQR, 0 to 6 cells/l]; P ⬍ 0.001), as
was the CSF protein concentration (111 mg/dl [IQR, 46 to 376
mg/dl] versus 42 mg/dl [IQR, 29 to 69 mg/dl], respectively; P ⬍
0.001) (Table 4).
For all 23 isolates (17.8%) for which an organism was observed
on direct Gram stain of the specimen, antimicrobial treatment was
initiated in the patients. Of the 69 culture-positive specimens
(53.5%) with negative specimen Gram stain (i.e., no organisms,
no polymorphonuclear cells [PMN] observed), only 7 patients
were treated (P ⬍ 0.001). The remaining 37 positive specimens
(28.7%) had PMN cells but no organisms seen on specimen Gram
stain. These cases were almost evenly split, with 19 patients
(51.4%) receiving antimicrobial therapy and 18 patients (48.6%)
not receiving therapy. For the 49 patients from whom an organism
was isolated in the CSF culture, therapy did not differ between
immunocompromised and immunocompetent patients (41.4
versus 37.1%, respectively; P ⫽ 0.678).
Treatment of anaerobic bacteria. Eight patients (22.9%) with
CSF cultures growing anaerobic isolates received antimicrobial
therapy. Table 5 highlights the differences between the patients
with anaerobic isolates who received antimicrobials and those
who did not receive therapy. Patients were more likely to receive
treatment if they had CNS hardware (75.0 versus 11.1%; P ⫽
0.001) or if they had a positive specimen Gram stain with either an
organism or PMN cells (87.5 versus 22.2%; P ⫽ 0.002). An increased proportion of neutrophils in the CSF cell count (median,
53 versus 0% neutrophils; P ⬍ 0.001) was also associated with the
decision to treat the patient. Although clinically significant isolates
seem to grow slightly faster than isolates for which patients did not
receive antimicrobial therapy (median, 2.5 versus 3 days), the difference was not statistically significant (P ⫽ 0.08). Other parameters, such as immunocompromised state, recent surgical procedure, or CSF chemistries did not play a consistent role in the
decision to treat.
Of note, two patients who received treatment did not have
CNS hardware. One patient was a man who presented with altered
mental status and was found to have a pilonidal cyst. Brain magnetic resonance imaging (MRI) showed leptomeningeal enhancement, and the patient’s CSF sample had an elevated protein (60
mg/dl) and nucleated cell count (111 cells/l), with a neutrophilic
predominance. The specimen Gram stain demonstrated polymorphonuclear cells and Gram-negative bacilli, and the culture
grew B. thetaiotaomicron; growth was observed on BBA in just 2
days, and metronidazole was initiated in the patient as soon as an

Clinical characteristic

Treated
(n ⫽ 8)

Untreated
(n ⫽ 27)

Pa

Fever (n [%])
CNS hardware (n [%])
Immunocompromised (n [%])
Neurosurgery within 90 days (n [%])

1 (12.5)
6 (75.0)
1 (12.5)
2 (25.0)

1 (3.7)
3 (11.1)
5 (18.5)
1 (3.7)

0.41
0.001
⬎0.9
0.124

No. with specimen Gram stain
Organism detected
PMN (no organism)
Negative (no organism, no PMN)

0.002b
5
2
1

0
6
21

No. of CSF nucleated cells/l
(median [IQR])
% neutrophils (median [IQR])

58 (0, 364)

0 (0, 5)

0.088

53 (22, 91)

0 (0, 5)

<0.001

CSF protein (median [IQR]) (mg/dl)
CSF Glucose (median [IQR]) (mg/dl)
Single isolate growth
Days of incubation for detection
(median [IQR])

70 (25, 176)
20 (11, 76)
7 (87.5)
2.5 (0.8–4.3)

36 (25, 56)
65 (60, 73)
25 (92.6)
3.0 (1–5)

0.323
0.096
0.553
0.08

a
b

P values in bold type are those that are statistically significant at a P value of ⬍0.05.
P value calculated for negative Gram stain versus organism/PMN on Gram stain.

anaerobic pathogen was suspected. After this change in his antimicrobial therapy, his infection cleared.
The second patient was a man with a history of melanoma who
presented with altered mental status, nausea, vomiting, and headache. A head computed tomography (CT) scan showed only dilated ventricles, and his CSF had elevated protein (518 mg/dl) and
nucleated cells (145 cells/l). A specimen Gram stain showed the
presence of polymorphonuclear cells, and 3 consecutive CSF specimen cultures received over a 7-day period grew P. acnes. Despite
appropriate antimicrobial therapy, the patient was also found to
have metastatic cancer, and he eventually died as a result of this
disease (11).
DISCUSSION

The contemporary patterns of bacterial meningitis in the United
States are markedly different from those 30 years ago. As a result of
this epidemiologic change, clinical microbiology laboratories
must be prepared to isolate bacterial pathogens that may not historically be considered common causes of bacterial meningitis. In
this study, we demonstrate that bacterial pathogens classically associated with meningitis now comprise a minority of pathogens
isolated at a tertiary care medical center. Additionally, we demonstrate that anaerobic organisms may be clinically significant
pathogens in bacterial meningitis. By adding a single piece of medium, incubated anaerobically, to our standard laboratory procedure for CSF cultures, we were able to capture these clinically
relevant organisms.
Although anaerobes are often considered contaminants because they are normal flora on human skin and mucosal surfaces,
numerous case reports detail the existence and relevance of anaerobic organisms in bacterial meningitis (12–21). These reports
highlight some of the predisposing factors for anaerobic menin-
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CSF analyte
Nucleated cells (cells/l)
Neutrophils (%)
Lymphocytes (%)
Protein (mg/dl)
Glucose (mg/dl)
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Data by antimicrobial
treatment status

b
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bials is complex and based only in part on the result of a CSF
culture. Clinicians take into account patient history and presenting symptoms, with special emphasis placed on the results of CSF
studies, including direct specimen Gram stain, protein and glucose concentrations, nucleated cell count, and the relative percentage of neutrophils identified (12, 13).
This study has several strengths. By evaluating 2 years worth of
laboratory and clinical data, we were able to present a detailed
view of the isolates attributed to bacterial meningitis in the postvaccination era at an academic medical center. The clinical data
collected on each patient were extensive, and the inclusion of an
infectious diseases specialist on our study team allowed for the
most accurate evaluation possible of the clinical significance of
each isolate recovered from the CSF specimens. That being said,
this study is not without limitations. As with any retrospective
study, the data collected may be incomplete, and it is difficult to
evaluate the clinical significance of any one laboratory isolate with
a chart review. Because separate physician orders for aerobic and
anaerobic bacterial CSF cultures do not exist within our system,
we cannot comment on clinical suspicion of anaerobic meningitis
prior to the routine addition of BBA to CSF cultures. This study
was conducted at a large tertiary care academic medical center and
thus may not be reflective of other care settings. Additionally, our
laboratory serves an adult population only. Children, and neonates especially, have a distinct set of risk factors that alter the
microbes implicated in pediatric bacterial meningitis, and our
data cannot be extrapolated to the pediatric population. Finally,
although we had large numbers of CSF specimens submitted for
culture, the number of positive results over the 2-year study period remained relatively small.
The results of this study highlight the change in the contemporary epidemiology of bacterial meningitis in the United States.
Our results demonstrate that the simple inexpensive addition of
an anaerobically incubated BBA plate to the CSF culture protocol
aids in the recovery of clinically significant anaerobic isolates from
CSF specimens. The patients with meningitis from anaerobic bacteria are not limited to patients with CNS hardware or to immunosuppressed patients. In 1998, Sabeen Askari and Charles Cartwright noted (24):
The clinical consequences of bacterial infection of the central nervous system guarantee that the diagnosis of such
infections will remain a high priority for clinicians and
laboratorians alike. In the face of a disease whose epidemiology continues to change, it seems likely that periodic reassessments of how best to make a diagnosis of bacterial
meningitis will be necessary.
This observation still holds true today.
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gitis, such as infection (otitis media or upper respiratory infections), trauma, a recent surgical procedure, or the presence of
CNS hardware, in particular a ventriculoperitoneal shunt (14).
These reports also emphasize the fact that in a symptomatic patient with a CSF pure culture of the organism, it is unlikely that the
anaerobic organism is a mere contaminant (13). Still, because anaerobes require specific growth conditions not routinely provided
for CSF specimens, the true incidence of anaerobic bacterial meningitis remains unknown.
In our study population, approximately one-third of all organisms isolated from CSF specimens after the addition of the brucella blood agar were anaerobic bacteria. A subset of these anaerobes were considered clinically significant, and the patients were
treated with antimicrobial therapy plus shunt revision where appropriate. In patients with a CNS shunt, the presence of anaerobic
bacteria in the CSF has been associated with low-grade infection
that resolves upon exchange of the shunt (18, 22). Additionally,
early recognition of shunt infection and subsequent replacement
can decrease expensive repeat hospitalizations, infectious workup,
and unnecessarily broad antimicrobial treatment.
Anaerobic meningitis is not limited to patients with CNS hardware, and two of our study patients with CSF anaerobic isolates
did not have a shunt or a history of a recent neurosurgical procedure. Although these represent only two cases of community-acquired anaerobic meningitis from a total of 2,302 cultures, the
importance of recovering anaerobes from CSF specimens cannot
be overstated. Prompt recovery of a pathogen, if present, can expedite appropriate treatment and minimize additional medical
interventions and/or diagnostic studies. Anaerobic bacteria remain highly susceptible to antimicrobials, meaning that discovery
of an anaerobic pathogen can allow for streamlining of antimicrobial therapy (14).
The purchase of BBA and an increase in labor time are laboratory costs that were considered with the institution of this protocol. The addition of a BBA plate can be quite easily incorporated
into the existing laboratory procedure for the culture of CSF specimens. The cost of the additional medium is approximately $4.00
per specimen, making this an inexpensive intervention. Due to the
relatively low growth rate of anaerobic bacteria, an extended incubation time for the BBA is necessary; in this study, 80% of all
anaerobes recovered had been isolated within the first 4 days. No
plates were incubated for ⬎6 days, and thus we lack data to promote or refute prolonged incubation of CSF cultures. Although
increased incubation times may marginally increase laboratory
costs, this cost may be outweighed by cost savings at a hospital
level due to timely pathogen identification and appropriate antimicrobial therapy, not to mention the benefit to the patient. At a
minimum, we recommend that patients with CNS hardware have
an anaerobic component to their CSF culture, although the community-acquired anaerobic meningitis cases highlight the importance of taking an unbiased approach to the addition of the BBA
medium.
The anaerobic isolates in our population were found to be
Propionibacterium spp. or P. acnes, with the exception of a single B.
thetaiotaomicron isolate. It is well known that Propionibacterium is
a component of the normal skin flora and that P. acnes is especially
prevalent on areas of skin with a high density of sebaceous glands,
such as the scalp (23). For this reason, teasing out true infection
versus a contaminated culture can be a difficult task for clinicians.
As this study shows, the decision to treat a patient with antimicro-
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